Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

SOTER BIO INC.

Filed by TENAGRITY SOLUTIONS, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
88357c14-b0d7-4d61-b7a3-3d779d2a2734
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

DEF · Defense

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

DIS · Disaster Planning/Emergencies

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

BUD · Budget/Appropriations

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.